CosMedix Elite RX Clean Exfoliating Cleanser - 150ml

CosMedix Elite RX Clean Exfoliating Cleanser - 150ml

Marsoni

M251S

$89.00

Get it in 3 business days with 1 day shipping. Friday, May 29

CosMedix Elite RX Clean Exfoliating Cleanser - 150mlRX Clean is an Exfoliating Cleanser with 10% L Lactic Acid that removes oil, dirt and daily impurities for softer, even looking skin tone and texture after a single use. Benefits: Exfoliates dead skin Helps improve the appearance of skin texture Evens the look of skin tone Cleanses oily skin Skin Concern: Uneven skin tone Oily acne prone skin Mature skin

Easy Shipping

Quick Dispatch:

Your CosMedix Elite RX Clean Exfoliating Cleanser - 150ml orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your CosMedix Elite RX Clean Exfoliating Cleanser - 150ml ships.

Need Help?
Questions about CosMedix Elite RX Clean Exfoliating Cleanser - 150ml, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for CosMedix Elite RX Clean Exfoliating Cleanser - 150ml in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

This lip balm has worked well for me overall. It does what I want from an SPF lip balm and I have not had any major complaints using it. The only minor downside is that it is a little soft, so when you first start using a tube you may notice a few small chunks on your lips. That has not been a big enough issue to bother me much, but it is worth mentioning. Aside from that, it has been a good product and I would keep using it.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on March 10, 2026